BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31372638)

  • 1. A CRISPR-Cas9 screen identifies essential CTCF anchor sites for estrogen receptor-driven breast cancer cell proliferation.
    Korkmaz G; Manber Z; Lopes R; Prekovic S; Schuurman K; Kim Y; Teunissen H; Flach K; Wit E; Galli GG; Zwart W; Elkon R; Agami R
    Nucleic Acids Res; 2019 Oct; 47(18):9557-9572. PubMed ID: 31372638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CUEDC1 is a primary target of ERα essential for the growth of breast cancer cells.
    Lopes R; Korkmaz G; Revilla SA; van Vliet R; Nagel R; Custers L; Kim Y; van Breugel PC; Zwart W; Moumbeini B; Manber Z; Elkon R; Agami R
    Cancer Lett; 2018 Nov; 436():87-95. PubMed ID: 30145202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAP18 facilitates CTCF-mediated chromatin accessible to regulate enhancer activity in breast cancer.
    Sun G; Wei Y; Zhou B; Wang M; Luan R; Bai Y; Li H; Wang S; Zheng D; Wang C; Wang S; Zeng K; Liu S; Lin L; He M; Zhang Q; Zhao Y
    Cell Death Differ; 2023 May; 30(5):1260-1278. PubMed ID: 36828916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Roles for BET Family Members in Estrogen Receptor α Enhancer Function and Gene Regulation in Breast Cancer Cells.
    Murakami S; Li R; Nagari A; Chae M; Camacho CV; Kraus WL
    Mol Cancer Res; 2019 Dec; 17(12):2356-2368. PubMed ID: 31551256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function.
    Jiang G; Wang X; Sheng D; Zhou L; Liu Y; Xu C; Liu S; Zhang J
    Theranostics; 2019; 9(22):6501-6516. PubMed ID: 31588232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering essential cistromes using genome-wide CRISPR screens.
    Fei T; Li W; Peng J; Xiao T; Chen CH; Wu A; Huang J; Zang C; Liu XS; Brown M
    Proc Natl Acad Sci U S A; 2019 Dec; 116(50):25186-25195. PubMed ID: 31727847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells.
    de Souza Rocha Simonini P; Breiling A; Gupta N; Malekpour M; Youns M; Omranipour R; Malekpour F; Volinia S; Croce CM; Najmabadi H; Diederichs S; Sahin O; Mayer D; Lyko F; Hoheisel JD; Riazalhosseini Y
    Cancer Res; 2010 Nov; 70(22):9175-84. PubMed ID: 20978187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTCF modulates Estrogen Receptor function through specific chromatin and nuclear matrix interactions.
    Fiorito E; Sharma Y; Gilfillan S; Wang S; Singh SK; Satheesh SV; Katika MR; Urbanucci A; Thiede B; Mills IG; Hurtado A
    Nucleic Acids Res; 2016 Dec; 44(22):10588-10602. PubMed ID: 27638884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable Extent of Lineage-Specificity and Developmental Stage-Specificity of Cohesin and CCCTC-Binding Factor Binding Within the Immunoglobulin and T Cell Receptor Loci.
    Loguercio S; Barajas-Mora EM; Shih HY; Krangel MS; Feeney AJ
    Front Immunol; 2018; 9():425. PubMed ID: 29593713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancer release and retargeting activates disease-susceptibility genes.
    Oh S; Shao J; Mitra J; Xiong F; D'Antonio M; Wang R; Garcia-Bassets I; Ma Q; Zhu X; Lee JH; Nair SJ; Yang F; Ohgi K; Frazer KA; Zhang ZD; Li W; Rosenfeld MG
    Nature; 2021 Jul; 595(7869):735-740. PubMed ID: 34040254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzothiophenone Derivatives Targeting Mutant Forms of Estrogen Receptor-α in Hormone-Resistant Breast Cancers.
    Singh K; Munuganti RSN; Lallous N; Dalal K; Yoon JS; Sharma A; Yamazaki T; Cherkasov A; Rennie PS
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTCF knockout in zebrafish induces alterations in regulatory landscapes and developmental gene expression.
    Franke M; De la Calle-Mustienes E; Neto A; Almuedo-Castillo M; Irastorza-Azcarate I; Acemel RD; Tena JJ; Santos-Pereira JM; Gómez-Skarmeta JL
    Nat Commun; 2021 Sep; 12(1):5415. PubMed ID: 34518536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Estrogen Receptor α-Cistrome Beyond Breast Cancer.
    Droog M; Mensink M; Zwart W
    Mol Endocrinol; 2016 Oct; 30(10):1046-1058. PubMed ID: 27489947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential in
    Amândio AR; Beccari L; Lopez-Delisle L; Mascrez B; Zakany J; Gitto S; Duboule D
    Genes Dev; 2021 Nov; 35(21-22):1490-1509. PubMed ID: 34711654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KLF17 attenuates estrogen receptor α-mediated signaling by impeding ERα function on chromatin and determines response to endocrine therapy.
    Ali A; Ielciu I; Alkreathy HM; Khan AA
    Biochim Biophys Acta; 2016 Jul; 1859(7):883-95. PubMed ID: 27107895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional genome architectural CCCTC-binding factor makes choice in duplicated enhancers at Pcdhα locus.
    Wu Y; Jia Z; Ge X; Wu Q
    Sci China Life Sci; 2020 Jun; 63(6):835-844. PubMed ID: 32249388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of CTCF-associated chromatin neighborhood inhibits TAL1-driven oncogenic transcription program and leukemogenesis.
    Li Y; Liao Z; Luo H; Benyoucef A; Kang Y; Lai Q; Dovat S; Miller B; Chepelev I; Li Y; Zhao K; Brand M; Huang S
    Nucleic Acids Res; 2020 Apr; 48(6):3119-3133. PubMed ID: 32086528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasis.
    Padua MB; Bhat-Nakshatri P; Anjanappa M; Prasad MS; Hao Y; Rao X; Liu S; Wan J; Liu Y; McElyea K; Jacobsen M; Sandusky G; Althouse S; Perkins S; Nakshatri H
    Breast Cancer Res; 2018 May; 20(1):35. PubMed ID: 29720215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of a -35 kb Enhancer Impairs CTCF Binding and
    Liu Q; Thoms JAI; Nunez AC; Huang Y; Knezevic K; Packham D; Poulos RC; Williams R; Beck D; Hawkins NJ; Ward RL; Wong JWH; Hesson LB; Sloane MA; Pimanda JE
    Clin Cancer Res; 2018 Sep; 24(18):4602-4611. PubMed ID: 29898989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.